We are live on
!
Find out more
EI
EAM Investors Portfolio holdings
AUM
$866M
1-Year Est. Return
377.14%
This Fund
S&P 500
This Quarter
Est. Return
+32.61%
1 Year Est. Return
+377.14%
3 Year Est. Return
+5,228.32%
5 Year Est. Return
+49,813.17%
10 Year Est. Return
+19,957,666.26%
AUM
$610M
AUM Growth
+$17.3M
(+2.9%)
Cap. Flow
-$82.5M
Cap. Flow
% of AUM
-13.54%
Top 10 Holdings %
Top 10 Hldgs %
9.29%
Holding
412
New
138
Increased
22
Reduced
119
Closed
133
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Impinj
PI
|
+$3.89M |
| 2 |
KZR
Kezar Life Sciences
KZR
|
+$3.86M |
| 3 |
PENG
Penguin Solutions Inc
PENG
|
+$3.7M |
| 4 |
Forward Air
FWRD
|
+$3.51M |
| 5 |
Rambus
RMBS
|
+$3.49M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
OptimizeRx
OPRX
|
+$7.23M |
| 2 |
PLXP
PLx Pharma Inc. Common Stock
PLXP
|
+$7.18M |
| 3 |
PAVmed
PAVM
|
+$6.57M |
| 4 |
EVRI
Everi Holdings
EVRI
|
+$4.68M |
| 5 |
Celldex Therapeutics
CLDX
|
+$4.67M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.42% |
| 2 | Industrials | 18.61% |
| 3 | Healthcare | 11.98% |
| 4 | Consumer Discretionary | 11.9% |
| 5 | Financials | 9.78% |
Similar funds
NEPWA
RWM
MCM
HP
OMG
RB
BGC
ICCFIA
EAM Investors's Q4 2021 Portfolio in Review
As of Q4 2021, EAM Investors held 412 positions worth $610M, up 2.9% from $593M the previous quarter. Its ten largest holdings account for 9.3% of the portfolio.
EAM Investors withdrew a net $82.5M in Q4 2021, closing 133 positions and reducing 119 holdings. Its most notable exit was OptimizeRx, an estimated $7.23M position sold in full.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 21% a quarter earlier, followed by Industrials and Healthcare.
Against the trend, EAM Investors opened a new position in Impinj worth $4.76M.
- EAM Investors's largest Q4 2021 buy was Impinj: 53,617 shares worth $4.76M.
- EAM Investors added most to BlueLinx in Q4 2021, an estimated $2.56M increase.
- EAM Investors's biggest Q4 2021 reduction was Aehr Test Systems, cutting an estimated $3.65M.
- EAM Investors fully exited OptimizeRx in Q4 2021, selling an estimated $7.23M.
- EAM Investors's ten largest holdings make up 9.3% of its $610M portfolio in Q4 2021.
- EAM Investors opened 138 new positions and closed 133 in Q4 2021.
- EAM Investors's portfolio value rose 2.9% quarter-over-quarter to $610M.
Based on EAM Investors's 13F filing for Q4 2021, filed 11 Feb 2022.